IBM Acquires Merge Healthcare Image Management Platform
By HospiMedica International staff writers Posted on 16 Aug 2015 |
The newly formed IBM (Armonk, NY, USA) Watson health analytics unit will soon be able to read medical images, due to the planned acquisition of Merge Healthcare (Chicago, IL, USA) for USD 1 billion.
IBM plans to combine data and images from Merge Healthcare's medical imaging management platform with Watson's cloud-based healthcare computing system in an effort to unlock the value of medical images, helping physicians make better patient care decisions. The combined platform will help physicians and researchers collate and analyze data, such as a patient's medical and family history, data on others with similar symptoms, and clinical research, trials, and outcomes. Using the Watson supercomputer to analyze the high volumes of data, complex questions can be posed in natural language and evidence-based answers can be delivered.
Merge’s technology platforms are used at more than 7,500 US healthcare sites, as well as most of the world’s leading clinical research institutes and pharmaceutical firms, helping to manage the burgeoning body of medical images. The vision is that these organizations could use the Watson Health Cloud to uncover new insights from a consolidated, patient-centric view of current and historical images, electronic health records (EHRs), data from wearable devices, and other related medical data, in a HIPAA-enabled environment.
“As a proven leader in delivering healthcare solutions for over 20 years, Merge is a tremendous addition to the Watson Health platform,” said John Kelly, senior vice president of IBM Research and Solutions Portfolio. “Watson’s powerful cognitive and analytic capabilities, coupled with those from Merge and our other major strategic acquisitions, position IBM to partner with healthcare providers, research institutions, biomedical companies, insurers and other organizations committed to changing the very nature of health and healthcare in the 21st century.”
“Combining Merge’s leading medical imaging solutions with the world-class machine learning and analytics capabilities of IBM’s Watson Health is the future of healthcare technology,” said Michael W. Ferro, Jr., chairman of Merge Healthcare. “Merge’s leading technology and proven expertise represent a unique combination of assets that will deliver unparalleled value to Watson Health clients. Together, we will unlock unprecedented new opportunities to improve patient diagnostics and deliver enhanced care.”
In April 2015, IBM announced the acquisitions of Explorys, developer of a cloud computing platform used by 26 major healthcare systems, and Phytel, a developer of cloud-based services that aim to optimize care in light of new government regulations and shifting reimbursement models. The move also comes just a few months after IBM created the Watson Health business unit and formed med tech alliances with Medtronic (Dublin, Ireland), Johnson & Johnson (J&J; New Brunswick, NJ, USA), and Apple (Cupertino, CA, USA).
Related Links:
IBM
Merge Healthcare
Medtronic
IBM plans to combine data and images from Merge Healthcare's medical imaging management platform with Watson's cloud-based healthcare computing system in an effort to unlock the value of medical images, helping physicians make better patient care decisions. The combined platform will help physicians and researchers collate and analyze data, such as a patient's medical and family history, data on others with similar symptoms, and clinical research, trials, and outcomes. Using the Watson supercomputer to analyze the high volumes of data, complex questions can be posed in natural language and evidence-based answers can be delivered.
Merge’s technology platforms are used at more than 7,500 US healthcare sites, as well as most of the world’s leading clinical research institutes and pharmaceutical firms, helping to manage the burgeoning body of medical images. The vision is that these organizations could use the Watson Health Cloud to uncover new insights from a consolidated, patient-centric view of current and historical images, electronic health records (EHRs), data from wearable devices, and other related medical data, in a HIPAA-enabled environment.
“As a proven leader in delivering healthcare solutions for over 20 years, Merge is a tremendous addition to the Watson Health platform,” said John Kelly, senior vice president of IBM Research and Solutions Portfolio. “Watson’s powerful cognitive and analytic capabilities, coupled with those from Merge and our other major strategic acquisitions, position IBM to partner with healthcare providers, research institutions, biomedical companies, insurers and other organizations committed to changing the very nature of health and healthcare in the 21st century.”
“Combining Merge’s leading medical imaging solutions with the world-class machine learning and analytics capabilities of IBM’s Watson Health is the future of healthcare technology,” said Michael W. Ferro, Jr., chairman of Merge Healthcare. “Merge’s leading technology and proven expertise represent a unique combination of assets that will deliver unparalleled value to Watson Health clients. Together, we will unlock unprecedented new opportunities to improve patient diagnostics and deliver enhanced care.”
In April 2015, IBM announced the acquisitions of Explorys, developer of a cloud computing platform used by 26 major healthcare systems, and Phytel, a developer of cloud-based services that aim to optimize care in light of new government regulations and shifting reimbursement models. The move also comes just a few months after IBM created the Watson Health business unit and formed med tech alliances with Medtronic (Dublin, Ireland), Johnson & Johnson (J&J; New Brunswick, NJ, USA), and Apple (Cupertino, CA, USA).
Related Links:
IBM
Merge Healthcare
Medtronic
Latest Business News
- Johnson & Johnson Acquires Cardiovascular Medical Device Company Shockwave Medical
- Mindray to Acquire Chinese Medical Device Company APT Medical
- Olympus Acquires Korean GI Stent Maker Taewoong Medical
- Karl Storz Acquires British AI Specialist Innersight Labs
- Stryker to Acquire French Joint Replacement Company SERF SAS
- Medical Illumination Acquires Surgical Lighting Specialist Isolux
- 5G Remote-Controlled Robots to Enable Even Cross-Border Surgeries
- International Hospital Federation Announces 2023 IHF Award Winners
- Unprecedented AI Integration Transforming Surgery Landscape, Say Experts
- New WHO Guidelines to Revolutionize AI in Healthcare
- Getinge Acquires US-Based Medical Equipment Provider Healthmark Industries
- Global Surgical Lights Market Driven by Increasing Number of Procedures
- Global Capsule Endoscopy Market Driven by Demand for Accurate Diagnosis of Gastrointestinal Conditions
- Global OR Integration Market Driven by Need for Improved Workflow Efficiency and Productivity
- Global Endoscopy Devices Market Driven by Increasing Adoption of Endoscopes in Surgical Procedures
- Global Minimally Invasive Medical Devices Market Driven by Benefits of MIS Procedures